- Home
- NATR vs VSTM Comparison
NATR vs VSTM Comparison
Compare NATR & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | VSTM |
|---|---|---|
| Founded | 1972 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.6M | 470.7M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | NATR | VSTM |
|---|---|---|
| Price | $25.64 | $6.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $21.33 | $14.00 |
| AVG Volume (30 Days) | 127.5K | ★ 2.0M |
| Earning Date | 03-10-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $474,542,000.00 | $13,379,000.00 |
| Revenue This Year | $7.30 | $208.54 |
| Revenue Next Year | $3.44 | $251.40 |
| P/E Ratio | $32.15 | ★ N/A |
| Revenue Growth | 6.62 | ★ 33.79 |
| 52 Week Low | $11.01 | $4.01 |
| 52 Week High | $26.73 | $11.25 |
Technical Indicators
Market Signals| Indicator | NATR | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 69.72 | 46.33 |
| Support Level | $23.50 | $6.01 |
| Resistance Level | $26.73 | $6.53 |
| Average True Range (ATR) | 1.01 | 0.40 |
| MACD | 0.16 | 0.07 |
| Stochastic Oscillator | 78.04 | 69.61 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.